SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing significant market volatility after its latest earnings report and a cautious Q1 outlook, fueling a sharp debate among investors. Many in the community are calling the substantial price drop an overreaction, pointing to temporary supply constraints and future foundry growth as buying opportunities. Conversely, a strong bearish sentiment suggests the decline is a justified correction, citing ongoing competitive challenges and valuation concerns within the semiconductor sector.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune (ALT) is experiencing heightened trading activity and community discussion, largely fueled by its Breakthrough Therapy Designation for pemvidutide and escalating rumors of a potential buyout or partnership deal. This has led to a deeply divided investor sentiment, with bulls anticipating a significant re-rating in the competitive GLP-1/MASH sector, while skeptics point to historical challenges and ongoing legal concerns.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending due to reports of an imminent TikTok US spinoff deal, which includes Oracle, fueling speculation about its expanded role in social media data hosting. This development intensifies the ongoing debate among investors regarding Oracle's long-term growth from its significant AI and cloud infrastructure buildouts. The community is actively discussing whether the TikTok news will serve as a strong catalyst for a rebound or if concerns over the company's substantial debt and market skepticism will lead to a "sell the news" reaction.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is surging following news of a significant French government-backed facility for rare earth metals and alloys production, coupled with key partnerships advancing its Texas project. This underscores USAR's expanding integrated supply chain, drawing strong community interest and bullish sentiment amidst global efforts to secure critical mineral independence. The introduction of a 2x leveraged ETF also amplifies trading activity and highlights intense investor focus on the company's trajectory.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is actively trending due to significant community speculation driven by its ultra-low share float, with many anticipating a substantial short squeeze and rapid price movement. While some highlight its cash-heavy balance sheet and ongoing strategic review, a strong cautionary sentiment exists, with traders debating the high risk associated with the company's announced discontinuation of its lead drug candidate and exploration of winding down operations versus a potential speculative breakout.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is experiencing a massive surge as the community passionately anticipates reaching the $100 mark, driven by intense short squeeze narratives and mounting concerns over physical silver shortages. Bulls are largely dismissing calls for a pullback, highlighting strong industrial demand from sectors like solar and EVs, coupled with broader de-dollarization trends and inflation fears, as key catalysts.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies (ASTI) is trending amid surging interest in its flexible, featherweight thin-film solar technology, directly aligning with recent high-profile discussions about solar-powered AI data centers in space. The community is actively debating the stock's potential, fueled by news of strategic partnerships, a recent private placement, and confirmed involvement in major space constellation projects, leading to significant short-squeeze speculation given its low float.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp. is driving intense investor conversation due to its recent Memorandum of Understanding with the Indian government to establish a substantial post-quantum semiconductor center and prominent discussions on quantum security at the Davos World Economic Forum. The community is highly focused on the company's strategic position in securing critical infrastructure against future quantum threats, particularly for AI and IoT systems. This narrative, combined with high short interest, is fueling expectations for significant shifts in its valuation.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano (MOVE) is trending due to news of its all-stock merger with AI cloud computing firm Corvex, which recently secured a long-term NVIDIA H200 GPU deployment, fueling immense speculation around its low float. The community is sharply divided, with many anticipating significant upside driven by AI sector excitement, while others express caution about potential dilution and the stock's historical volatility.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is experiencing strong bullish sentiment as community discussions interpret Intel's recent disappointing earnings and execution challenges as a significant opportunity for AMD to capture market share. Investors are actively discussing AMD's strong positioning to capitalize on an anticipated industry-wide CPU shortage and surging AI and data center demand. While many are extremely optimistic about continued growth, some traders are cautioning that the stock may be overextended after its rapid ascent.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Replimune Group (NASDAQ:REPL) Sees Large Volume Increase - Time to Buy?

Replimune Group (NASDAQ:REPL) Sees Large Volume Increase - Still a Buy...

Replimune Group (NASDAQ:REPL) Trading Down 5.4% - Should You Sell?

Replimune Group (NASDAQ:REPL) Stock Price Down 5.4% - Here's What Happened...

Replimune Group, Inc. (NASDAQ:REPL) Receives Consensus Rating of "Moderate Buy" from Brokerages

Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) has received an average recommendation of "Moderate Buy" from the eleven analysts that are currently covering the firm, Marketbeat.com reports...

Replimune Group Sees Unusually High Options Volume (NASDAQ:REPL)

Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) was the target of unusually large options trading activity on Tuesday. Investors purchased 12,092 call options on the stock. This is an increase...

Replimune Group (NASDAQ:REPL) Shares Down 6.4% - What's Next?

Replimune Group (NASDAQ:REPL) Stock Price Down 6.4% - Time to Sell...

Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months

REPL shares soar 131.1% over the past three months after the FDA accepts its resubmitted BLA for the RP1/Opdivo combo in advanced melanoma.

Replimune Group (NASDAQ:REPL) Trading Up 4.8% - Should You Buy?

Replimune Group (NASDAQ:REPL) Trading 4.8% Higher - Here's Why...

Replimune Group, Inc. (NASDAQ:REPL) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eleven analysts that are presently covering the stock...

Replimune Group, Inc. $REPL Holdings Trimmed by Braidwell LP

Braidwell LP lowered its holdings in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 71.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange...

Replimune Group (NASDAQ:REPL) Director Kapil Dhingra Sells 3,169 Shares

Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) Director Kapil Dhingra sold 3,169 shares of Replimune Group stock in a transaction dated Tuesday, December 9th. The stock was sold at an average...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Policy uncertainty from Trump

Earnings & guidance

Options / dealer positioning

Liquidity & algos

Markets are reacting to a mix of policy headlines, earnings, and positioning. We want to hear what you think is driving volatility the most right now.

What&#39;s the biggest driver of market volatility right now?

Stocktwits

What's the biggest driver of market volatility right now?

REPL
Replimune Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest REPL News

REPLReplimune Group Inc